TWST - Latest News

Twist Bioscience Corporation (TWST), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $7.35B. Beta to the broader market is 2.22.

The article list below shows the most recent TWST headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent TWST Headlines

Cathie Wood Is Buying the CoreWeave Dip and Selling Palantir

247wallst.com - Nov 13, 2026

ARK stepped into a sliding AI infrastructure stock while quietly trimming a premium-priced winner. One date next week could decide whether that bet o

Twist Bioscience Q4 Earnings Call Highlights

marketbeat.com - Nov 12, 2026

Twist Bioscience NASDAQ: TWST reported 28% revenue growth and positive adjusted EBITDA for its fiscal fourth quarter, as demand for DNA, proteins and

Twist Bioscience: 3 Key Takeaways for Long-Term Investors

fool.com - Nov 12, 2026

Fourth-quarter revenue grew 28% year over year to $126. 6 million.

Twist Bioscience Corporation (TWST) Q4 2026 Earnings Call Transcript

seekingalpha.com - Nov 12, 2026

Twist Bioscience Corporation (TWST) Q4 2026 Earnings Call Transcript

Alger Mid Cap 40 ETF Q3 2026 Portfolio Review

seekingalpha.com - Nov 12, 2026

Twist Bioscience Corp. , Cloudflare Inc.

How News Affects TWST Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track TWST's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked TWST news questions

What is the latest TWST news headline?
The most recent TWST headline (Nov 13, 2026) is "Cathie Wood Is Buying the CoreWeave Dip and Selling Palantir". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
How fresh is the TWST news on this page?
News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
What TWST news moves options pricing?
Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
How can I track unusual TWST options activity related to news?
Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.